Stockreport

Revance Therapeutics down 7%, prices $100M share offering [Seeking Alpha]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF Underwriters have a 30-day option to purchase additional shares in an amount not to exceed 15% of the number of shares of common stock offered in the public offering. [Read more]